Skip to content

The use of wax softeners (ceruminolytics) before dewaxing: a randomised clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN49027203
Enrollment
140
Registered
2007-09-28
Start date
2007-01-02
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear, Nose and Throat: Ear dewaxing Ear, Nose and Throat Ear dewaxing

Interventions

Selected patients will be given an information sheet as well as having the procedure and study explained to them in a private clinic room and then asked to give written consent by the clinician or nur

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who, by the decision of the examining clinician, need to undergo dewaxing.

Exclusion criteria

Exclusion criteria: 1. Unable to provide informed consent 2. Any infected ears

Design outcomes

Primary

MeasureTime frame
Visual analogue scores for pain and discomfort for patient.

Secondary

MeasureTime frame
1. Time taken to perform procedure 2. Visual analogue score for ease of procedure for clinician

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026